SkyePharma PLC Given “Corporate” Rating at N+1 Singer (SKP)
SkyePharma PLC (LON:SKP) traded down 2.24% during mid-day trading on Thursday, hitting GBX 251.475. The stock had a trading volume of 400,098 shares. SkyePharma PLC has a 52 week low of GBX 56.015 and a 52 week high of GBX 266.00. The stock’s 50-day moving average is GBX 254.9 and its 200-day moving average is GBX 209.4. The company’s market cap is £115.7 million.
SkyePharma PLC is a pharmaceutical company. The Company validates drug delivery technologies to develop oral and inhalation pharmaceutical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.